Family studies have estimated that genetic risk factors contribute to nearly 60% of VTE risk*

*Kolin et al – Nature Scientific Reports

Genomics research in Thrombosis has recently resulted in:

• Next Generation Sequencing (NGS) panels
• 33 Genome-wide association studies (GWAS) Loci and Polygenic Risk Scores

There is a role for genomics in diagnostics of Thrombosis.

Read further details on this specific project

NIHR Rare Diseases BioResource recall study is open for recruitment - for further details please email: s.sivapalaratnam@nhs.net

Please note, patients being referred must be identified by a clinician to make sure that they meet the criteria of the project, and the clinician must have the patient’s permission to refer.

Find out more about the NIHR BioResource

RNA phenotyping in heritable platelet disorders
RNA phenotyping in unexplained inherited thrombosis